DLL3 作为连接 NECC 恶性进展与免疫抑制的关键枢纽,其治疗意义经类器官-TIL 共培养系统验证
DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL
68.9分
★★★☆☆
站内排序·非疗效
FRONTIER PAPERS
DLL3 serves as a pivotal hub bridging malignant progression and immunosuppression in NECC with therapeutic implications validated via the organoid-TIL
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。